Low-Dose Therapy for Burkitt's Passes Muster MedPage Today Investigators examined two similar regimens: standard dose-adjusted EPOCH-R (DA-EPOCH-R) for HIV-negative patients and short-course therapy with a double dose of rituximab (SC-EPOCH-RR). Patients treated with DA-EPOCH-R continued therapy for ... NIH study finds low-intensity therapy for Burkitt lymphoma is highly effective Low-intensity chemo works for Burkitt's lymphoma Low-intensity EPOCH-R regimen effective in immunodeficiency-associated ... |
